Literature DB >> 26211660

Intravenous Preload of Mesenchymal Stem Cells Rescues Erectile Function in a Rat Model of Cavernous Nerve Injury.

Akio Takayanagi1, Masanori Sasaki2,3,4, Yuko Kataoka-Sasaki2, Ko Kobayashi1, Yohei Matsuda1, Shinichi Oka2, Naoya Masumori1, Jeffery D Kocsis3,4, Osamu Honmou2,3,4.   

Abstract

INTRODUCTION: We evaluated the potential preventive effects and mechanisms of intravenously preloaded mesenchymal stem cells (MSCs) for erectile dysfunction (ED) in a cavernous nerve (CN) injury model.
METHODS: Male Sprague-Dawley (SD) rats were used for this study. Rats were randomized into two groups. One group was intravenously preloaded with MSCs (1.0 × 10(6) cells in 1 mL total fluid volume) and the other was infused with medium alone (1 mL Dulbecco's modified Eagle's medium [DMEM]) for sham control, respectively. Crushed CN injury was induced immediately after infusion. The surgeon was blind to the experimental conditions (MSC or medium). MAIN OUTCOME MEASURES: To assess erectile function, we measured the intracavernous pressure (ICP) and arterial pressure (AP) at 1 hour and 2 weeks after CN injury. After measuring the initial ICP/AP of pre-injury (normal) male SD rats, they were randomized into the two groups and infused with MSCs or medium. PKH26-labelled MSCs were used for tracking. To investigate the mRNA expression levels of neurotrophins in the major pelvic ganglia (MPG), we performed real-time quantitative real-time polymerase chain reaction.
RESULTS: The reduction of ICP/AP and area under the curve of ICP (ICP-AUC) in the MSC group was significantly lower than in the DMEM group (P < 0.05; P < 0.05) at 1 hour. The ICP/AP and ICP-AUC at 2 weeks post-injury in the MSC group was significantly higher than in the DMEM group (P < 0.01; P < 0.05). The preloaded PKH26-labelled MSCs were detected in the MPG and CN using confocal microscopy indicating homing of the cells to the injured nerve and ganglia. Glia cell-derived neurotrophic factor (GDNF) and neurturin, which are important neurotrophic factors for erection, had expression levels in MPG significantly higher in the MSC group than in the DMEM group (P < 0.01, 0.05).
CONCLUSION: Intravenous preload of MSCs before a CN injury may prevent or reduce experimental ED.
© 2015 International Society for Sexual Medicine.

Entities:  

Keywords:  Erectile Dysfunction; Mesenchymal Stem Cells; Transplantation

Mesh:

Substances:

Year:  2015        PMID: 26211660     DOI: 10.1111/jsm.12957

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  9 in total

1.  An experimental study: evaluating the tissue structure of penis with 2D-ShearWave™ Elastography.

Authors:  X-H Qiao; J-J Zhang; F Gao; F Li; Y Liu; L-X Xing; L-F Du; J-F Xing
Journal:  Int J Impot Res       Date:  2016-09-22       Impact factor: 2.896

2.  Expression of CD44 standard form and variant isoforms in human bone marrow stromal cells.

Authors:  Xiaofeng Wang; Zhenwu Du; Xiaojun Liu; Yang Song; Guizhen Zhang; Zhitao Wang; Qingyu Wang; Zhongli Gao; Yajun Wang; Wei Wang
Journal:  Saudi Pharm J       Date:  2017-04-21       Impact factor: 4.330

Review 3.  The Current Status of Stem-Cell Therapy in Erectile Dysfunction: A Review.

Authors:  Amanda B Reed-Maldonado; Tom F Lue
Journal:  World J Mens Health       Date:  2016-12-22       Impact factor: 5.400

4.  Intravenous Infusion of Bone Marrow-Derived Mesenchymal Stem Cells Reduces Erectile Dysfunction Following Cavernous Nerve Injury in Rats.

Authors:  Yohei Matsuda; Masanori Sasaki; Yuko Kataoka-Sasaki; Akio Takayanagi; Ko Kobayashi; Shinichi Oka; Masahito Nakazaki; Naoya Masumori; Jeffery D Kocsis; Osamu Honmou
Journal:  Sex Med       Date:  2017-12-21       Impact factor: 2.491

5.  Umbilical Cord-Derived Mesenchymal Stem Cells Improve TGF-β, α-SMA and Collagen on Erectile Dysfunction in Streptozotocin-Induced Diabetic Rats.

Authors:  Ade Indra Mukti; Syafruddin Ilyas; Syah Mirsya Warli; Agung Putra; Nur Rasyid; Delfitri Munir; Kamal Basri Siregar; Muhammad Ichwan
Journal:  Med Arch       Date:  2022-02

6.  Intravenous Infusion of Autoserum-Expanded Autologous Mesenchymal Stem Cells in Patients With Chronic Brain Injury: Protocol for a Phase 2 Trial.

Authors:  Shinichi Oka; Tomohiro Yamaki; Masanori Sasaki; Ryo Ukai; Mitsuhiro Takemura; Takahiro Yokoyama; Yuko Kataoka-Sasaki; Rie Onodera; Yoichi M Ito; Shigeki Kobayashi; Jeffery D Kocsis; Yasuo Iwadate; Osamu Honmou
Journal:  JMIR Res Protoc       Date:  2022-07-06

Review 7.  Innovative trends and perspectives for erectile dysfunction treatment: A systematic review.

Authors:  Ezzat A Ismail; Ahmed I El-Sakka
Journal:  Arab J Urol       Date:  2016-05-18

8.  Efficient Promotion of Autophagy and Angiogenesis Using Mesenchymal Stem Cell Therapy Enhanced by the Low-Energy Shock Waves in the Treatment of Erectile Dysfunction.

Authors:  Guan Qun Zhu; Seung Hwan Jeon; Woong Jin Bae; Sae Woong Choi; Hyun Cheol Jeong; Kang Sup Kim; Su Jin Kim; Hyuk Jin Cho; U Syn Ha; Sung Hoo Hong; Ji Youl Lee; Eun Bi Kwon; Sae Woong Kim
Journal:  Stem Cells Int       Date:  2018-08-29       Impact factor: 5.443

9.  Lipopolysaccharide-preconditioned allogeneic adipose-derived stem cells improve erectile function in a rat model of bilateral cavernous nerve injury.

Authors:  Zhenbin Zhang; Pan Nie; Wende Yang; Xiaolei Ma; Zehong Chen; Hongbo Wei
Journal:  Basic Clin Androl       Date:  2022-03-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.